Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine.

[1]  R. Spielmann,et al.  Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. , 1988, Journal of the American College of Cardiology.

[2]  M. Akers,et al.  Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. , 1988, Circulation.

[3]  D. Zipes,et al.  Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. , 1988, Circulation.

[4]  D. Zipes,et al.  Effects of ischemia on cardiac afferent sympathetic and vagal reflexes in dog. , 1988, The American journal of physiology.

[5]  D. Zipes,et al.  Time Course of Denervation of Efferent Sympathetic and Vagal Nerves After Occlusion of the Coronary Artery in the Canine Heart , 1988, Circulation research.

[6]  B. Mock,et al.  Simplified solid-state labeling of [123I]m-iodobenzylguanidine , 1988 .

[7]  W. Beierwaltes,et al.  Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  D. Zipes,et al.  Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmural myocardial infarction. , 1987, Circulation.

[9]  D. Zipes,et al.  Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic. , 1987, Circulation.

[10]  M. N. Levy,et al.  Task Force 2 : Sudden cardiac death Neural-cardiac interactions , 2005 .

[11]  D. Wyse,et al.  Antiarrhythmic efficacy of propranolol: comparison of low and high serum concentrations. , 1986, Journal of the American College of Cardiology.

[12]  F. Witkowski,et al.  Mechanisms controlling cardiac autonomic function and their relation to arrhythmogenesis , 1986 .

[13]  E. Prystowsky,et al.  Induction of ventricular tachycardia during programmed electrical stimulation: analysis of pacing methods. , 1986, Circulation.

[14]  M. Nakajo,et al.  Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  E. Haber,et al.  The heart and cardiovascular system , 1986 .

[16]  D. Zipes,et al.  Interruption of sympathetic and vagal-mediated afferent responses by transmural myocardial infarction. , 1985, Circulation.

[17]  J. Sisson,et al.  Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  M. Nakajo,et al.  Rapid clearance of iodine-131 MIBG from the heart and liver of patients with adrenergic dysfunction and pheochromocytoma. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  D. Zipes,et al.  Phenol Topically Applied to Canine Left Ventricular Epicardium Interrupts Sympathetic but Not Vagal Afferents , 1984, Circulation research.

[20]  K. Swedberg,et al.  Göteborg Metoprolol Trial: mortality and causes of death. , 1984, The American journal of cardiology.

[21]  J. Cohn,et al.  Regional differences in adrenergic function within the left ventricle. , 1984, The American journal of physiology.

[22]  D. McCarron.  Diuretic therapy for mild hypertension: the "real" cost of treatment. , 1984, The American journal of cardiology.

[23]  W. Beierwaltes,et al.  Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  W. Manger,et al.  Heart imaging in the diagnosis of pheochromocytoma and assessment of catecholamine uptake. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  D. Berman,et al.  Time to completed redistribution of thallium-201 in exercise myocardial scintigraphy: relationship to the degree of coronary artery stenosis. , 1983, American heart journal.

[26]  D. Zipes,et al.  Transmural Myocardial Infarction in the Dog Produces Sympathectomy in Noninfarcted Myocardium , 1983, Circulation.

[27]  W. Chilian,et al.  Regional Uptake of [3H]Norepinephrine by the Canine Left Ventricle 1 , 1982, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[28]  Furberg Cd,et al.  The beta‐blocker heart attack trial. , 1982 .

[29]  B. Pitt,et al.  Myocardial imaging in man with I-123 meta-iodobenzylguanidine. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  N. Clinthorne,et al.  Myocardial imaging with a radioiodinated norepinephrine storage analog. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  D. Zipes,et al.  Epicardial Phenol Interrupts Refractory Period Responses to Sympathetic but Not Vagal Stimulation in Canine Left Ventricular Epicardium and Endocardium , 1980, Circulation research.

[32]  W. Beierwaltes,et al.  Radiolabeled Adrenergic Neuron-Blocking Agents: Adrenomedullary Imaging with [131I] Iodobenzylguanidine , 1980 .

[33]  H. Wellens,et al.  Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia. , 1977, The American journal of cardiology.

[34]  E. Angelakos.  Regional Distribution of Catecholamines in the Dog Heart , 1965, Circulation research.